Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Cerilliant
US Department of Justice
Baxter
Farmers Insurance
Argus Health
Julphar
UBS

Generated: June 18, 2018

DrugPatentWatch Database Preview

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) and what is the scope of trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) freedom to operate?

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
is the generic ingredient in nine branded drugs marketed by Lannett, Lilly, Forest Pharms, Wyeth Ayerst, Bristol Myers Squibb, Alpharma Us Pharms, Lederle, Impax Labs, Purepac Pharm, and Pal Pak, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

Summary for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
US Patents:0
Tradenames:9
Applicants:10
NDAs:11
Clinical Trials: 21
DailyMed Link:trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) at DailyMed

US Patents and Regulatory Information for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006920-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Forest Pharms SULFALOID trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 080100-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett LANTRISUL trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 080123-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alpharma Us Pharms TRIPLE SULFA trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 080280-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Fish and Richardson
Moodys
Argus Health
Johnson and Johnson
Federal Trade Commission
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.